Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

NCT04248595 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Homoharringtonine
DRUG: Azacitidine

Sponsor

Ge Zheng